Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain Nanotech Investing
dynaCERT Presents HydraGEN at International Logistics Trade Fairs: Focus on Sustainable Supply Chains and Low-Emission Port Logistics Technology Investing
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 Nanotech Investing
Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025 Nanotech Investing
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome , a Rare Pediatric Congenital Heart Defect Nanotech Investing
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025 Nanotech Investing
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation Nanotech Investing
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors Nanotech Investing
